Teva North America recalls Divalproex Sodium Delayed-release Tablets USP, RX, 250 mg, 100 count bottles, Manufactured in Israel by: TEVA PHARMACEU…
- Recall date
- May 18, 2016
- Source
- U.S. Food & Drug Administration (FDA) — enforcement report
- Recall number
- D-1449-2016
- FDA classification
- Class III
- Brand / firm
- Teva North America
- Sold / distributed
- Nationwide and Puerto Rico
Why it was recalled
Failed Tablet/Capsule Specifications
Class III means the product violates regulations but is not likely to cause harm.
What was recalled
Divalproex Sodium Delayed-release Tablets USP, RX, 250 mg, 100 count bottles, Manufactured in Israel by: TEVA PHARMACEUTICALS IND. LTD. Jerusalem, 9777402, Israel, Manufactured for: TEVA PHARMACEUTICALS USA, INC. North Wales, PA 19454, NDC 0093-7440-01.
Get recall alerts
Free email alert whenever Teva North America has a new recall — straight from official government data. Unsubscribe anytime.
More recalls from: Teva North America